Correction: Effect of haloperidol on survival among critically ill adults with a high risk of delirium: The reduce randomized clinical trial (JAMA - Journal of the American Medical Association (2018) 319:7 (680-690) DOI: 10.1001/jama.2018.0160);Effect of haloperidol on survival among critically ill adults with a high risk of delirium the REDUCE randomized clinical trial

JAMA - Journal of the American Medical Association

Volumn 319, Issue 7, 2018, Pages 680-690

  Van Den Boogaard, Mark ^a   Slooter, Arjen J C ^b   Brüggemann, Roger J M ^a   Schoonhoven, Lisette ^a,c,d   Beishuizen, Albertus ^e   Vermeijden, J Wytze ^e   Pretorius, Danie ^f   De Koning, Jan ^g   Simons, Koen S ^h   Dennesen, Paul J W ⁱ   Van Der Voort, Peter H J ^j   Houterman, Saskia ^k   Van Der Hoeven, J G ^a   Pickkers, Peter ^a  

^a RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^d The National Institute for Health Research Health Protection Research Unit in Blood Borne and Sexually Transmitted Infections at University College London in partnership with UK Health Security Agency   (United Kingdom)

^e MEDISCH SPECTRUM TWENTE   (Netherlands)

^f ST JANSDAL HOSPITAL   (Netherlands)

^g MÁXIMA MEDICAL CENTER   (Netherlands)

^h JEROEN BOSCH HOSPITAL   (Netherlands)

ⁱ MEDICAL CENTER HAAGLANDEN   (Netherlands)

^j ONZE LIEVE VROUWE GASTHUIS   (Netherlands)

^k TILBURG UNIVERSITY   (Netherlands)

more..

Author keywords

[No Author keywords available]

Indexed keywords

HALOPERIDOL; PLACEBO; NEUROLEPTIC AGENT;

ADULT; AGED; AKATHISIA; ARTICLE; ARTIFICIAL VENTILATION; CONTROLLED STUDY; CRITICALLY ILL PATIENT; DELIRIUM; DOUBLE BLIND PROCEDURE; DRUG DOSAGE FORM COMPARISON; DRUG EFFECT; DRUG SAFETY; DRUG USE; DYSTONIA; EXTRAPYRAMIDAL SYMPTOM; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; INCIDENCE; INTENSIVE CARE UNIT; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MORTALITY RATE; MULTICENTER STUDY; MUSCLE RIGIDITY; MYOCLONUS; NETHERLANDS; NEUROPROTECTION; OUTCOME ASSESSMENT; PRIORITY JOURNAL; QT PROLONGATION; RANDOMIZED CONTROLLED TRIAL; RISK REDUCTION; SURVIVAL RATE; TIC; TREMOR; VERY ELDERLY; CLINICAL TRIAL; COMPARATIVE STUDY; CRITICAL ILLNESS; DOSE RESPONSE; MIDDLE AGED; MORTALITY; PROPORTIONAL HAZARDS MODEL; RISK FACTOR; SURVIVAL ANALYSIS;

ADULT; AGED; ANTIPSYCHOTIC AGENTS; CRITICAL ILLNESS; DELIRIUM; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HALOPERIDOL; HUMANS; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; RISK FACTORS; SURVIVAL ANALYSIS;

EID: 85042288744     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2018.3290     Document Type: Erratum

References (33)

1. Association AP. Diagnostic and Statistical Manual of Mental Disorders (DSM-5). Vol. 5th ed. Arlington, VA: American Psychiatric Publishing; 2013.
2. Ely EW, Gautam S, Margolin R, et al. The impact of delirium in the intensive care unit on hospital length of stay. Intensive Care Med. 2001;27(12): 1892-1900.
3. van den Boogaard M, Schoonhoven L, van der Hoeven JG, van Achterberg T, Pickkers P. Incidence and short-Term consequences of delirium in critically ill patients: A prospective observational cohort study. Int J Nurs Stud. 2012;49(7):775-783.
4. Ely EW, Shintani A, Truman B, et al. Delirium as a predictor of mortality in mechanically ventilated patients in the intensive care unit. JAMA. 2004;291(14):1753-1762.
5. Girard TD, Jackson JC, Pandharipande PP, et al. Delirium as a predictor of long-Term cognitive impairment in survivors of critical illness. Crit Care Med. 2010;38(7):1513-1520.
6. van den Boogaard M, Schoonhoven L, Evers AW, van der Hoeven JG, van Achterberg T, Pickkers P. Delirium in critically ill patients: impact on long-Term health-related quality of life and cognitive functioning. Crit Care Med. 2012;40(1): 112-118.
7. Patel RP, Gambrell M, Speroff T, et al. Delirium and sedation in the intensive care unit: survey of behaviors and attitudes of 1384 healthcare professionals. Crit Care Med. 2009;37(3):825-832.
8. Burry LD, Williamson DR, Mehta S, et al. Delirium and exposure to psychoactive medications in critically ill adults: A multi-centre observational study. J Crit Care. 2017;42:268-274.
9. Mo Y, Zimmermann AE, Thomas MC. Practice patterns and opinions on current clinical practice guidelines regarding the management of delirium in the intensive care unit. J Pharm Pract. 2017;30(2): 162-171.
10. Kalisvaart KJ, de Jonghe JF, Bogaards MJ, et al. Haloperidol prophylaxis for elderly hip-surgery patients at risk for delirium: A randomized placebo-controlled study. J AmGeriatr Soc. 2005; 53(10):1658-1666.
11. Kaneko T, Cai J, Ishikura T, Kobayashi M, Naka T, Kaibara N. Prophylactic consecutive administration of haloperidol can reduce the occurrence of postoperative delirium in gastrointestinal surgery. Yonago Acta Med. 1999;42(3):179-184.
12. Wang W, Li HL, Wang DX, et al. Haloperidol prophylaxis decreases delirium incidence in elderly patients after noncardiac surgery: A randomized controlled trial. Crit Care Med. 2012;40(3):731-739.
13. Page VJ, Ely EW, Gates S, et al. Effect of intravenous haloperidol on the duration of delirium and coma in critically ill patients (Hope-ICU): A randomised, double-blind, placebo-controlled trial. Lancet Respir Med. 2013;1(7):515-523.
14. van den Boogaard M, Schoonhoven L, van Achterberg T, van der Hoeven JG, Pickkers P. Haloperidol prophylaxis in critically ill patients with a high risk for delirium. Crit Care. 2013;17(1):R9.
15. Al-Qadheeb NS, Skrobik Y, Schumaker G, et al. Preventing ICU subsyndromal delirium conversion to delirium with low-dose IV haloperidol: A double-blind, placebo-controlled pilot study. Crit Care Med. 2016;44(3):583-591.
16. van den Boogaard M, Slooter AJ, Brüggemann RJ, et al. Prevention of ICU delirium and delirium-related outcome with haloperidol: A study protocol for a multicenter randomized controlled trial. Trials. 2013;14:400.
17. van den Boogaard M, Pickkers P, Slooter AJ, et al. Development and validation of PRE-DELIRIC (PREdiction of DELIRium in ICU patients) delirium prediction model for intensive care patients: observational multicentre study. BMJ. 2012;344: E420.
18. van den Boogaard M, Schoonhoven L, Maseda E, et al. Recalibration of the delirium prediction model for ICU patients (PRE-DELIRIC): A multinational observational study. Intensive Care Med. 2014;40(3):361-369.
19. Ely EW, Inouye SK, Bernard GR, et al. Delirium in mechanically ventilated patients: validity and reliability of the confusion assessment method for the intensive care unit (CAM-ICU). JAMA. 2001;286 (21):2703-2710.
20. Ely EW, Margolin R, Francis J, et al. Evaluation of delirium in critically ill patients: validation of the Confusion Assessment Method for the Intensive Care Unit (CAM-ICU). Crit Care Med. 2001;29(7): 1370-1379.
21. Bergeron N, Dubois MJ, Dumont M, Dial S, Skrobik Y. Intensive care delirium screening checklist: Evaluation of a new screening tool. Intensive Care Med. 2001;27(5):859-864.
22. Simons KS, Laheij RJ, van den Boogaard M, et al. Dynamic light application therapy to reduce the incidence and duration of delirium in intensive-care patients: A randomised controlled trial. Lancet Respir Med. 2016;4(3):194-202.
23. Schuurmans MJ, Shortridge-Baggett LM, Duursma SA. The delirium observation screening scale: A screening instrument for delirium. Res Theory Nurs Pract. 2003;17(1):31-50.
24. Gusmao-Flores D, Salluh JI, Chalhub RA, Quarantini LC. The confusion assessment method for the intensive care unit (CAM-ICU) and intensive care delirium screening checklist (ICDSC) for the diagnosis of delirium: A systematic review and meta-Analysis of clinical studies. Crit Care. 2012;16 (4):R115.
25. Abdo WF, van de Warrenburg BP, Burn DJ, Quinn NP, Bloem BR. The clinical approach to movement disorders. Nat Rev Neurol. 2010;6(1):29- 37.
26. Wassenaar A, van den Boogaard M, van Achterberg T, et al. Multinational development and validation of an early prediction model for delirium in ICU patients. Intensive Care Med. 2015; 41(6):1048-1056.
27. Hauck WW, Anderson S, Marcus SM. Should we adjust for covariates in nonlinear regression analyses of randomized trials? Control Clin Trials. 1998;19(3):249-256.
28. Hernández AV, Steyerberg EW, Habbema JD. Covariate adjustment in randomized controlled trials with dichotomous outcomes increases statistical power and reduces sample size requirements. J Clin Epidemiol. 2004;57(5):454-460.
29. O'Brien PC, Fleming TR. A multiple testing procedure for clinical trials. Biometrics. 1979;35(3): 549-556.
30. van Gool WA, van de Beek D, Eikelenboom P. Systemic infection and delirium: When cytokines and acetylcholine collide. Lancet. 2010;375(9716): 773-775.
31. Flacker JM, Lipsitz LA. Neural mechanisms of delirium: current hypotheses and evolving concepts. J Gerontol A Biol Sci Med Sci. 1999;54(6): B239-B246.
32. Milbrandt EB, Kersten A, Kong L, et al. Haloperidol use is associated with lower hospital mortality in mechanically ventilated patients. Crit Care Med. 2005;33(1):226-229.
33. Barr J, Pandharipande PP. The pain, agitation, and delirium care bundle: synergistic benefits of implementing the 2013 Pain, Agitation, and Delirium Guidelines in an integrated and interdisciplinary fashion. Crit Care Med. 2013;41(9) (suppl 1):S99-S115.